Optimizing Y90 Therapy for Radiation Lobectomy
NCT: NCT04390724 · RECRUITING
Brief Summary
HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.
Frequently Asked Questions
What is Optimizing Y90 Therapy for Radiation Lobectomy?
Optimizing Y90 Therapy for Radiation Lobectomy is a clinical trial registered under NCT04390724. Current status: RECRUITING.
What is the status of NCT04390724?
The current status of NCT04390724 (Optimizing Y90 Therapy for Radiation Lobectomy) is: RECRUITING.
When did Optimizing Y90 Therapy for Radiation Lobectomy start?
Optimizing Y90 Therapy for Radiation Lobectomy started on 2020-07-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.